Pluri Inc. - Common Stock (PLUR)

Pluri Inc. is a biotechnology company focused on advancing cell therapy and regenerative medicine through its innovative technologies

The company specializes in developing and commercializing products and therapies aimed at treating incurable diseases and addressing unmet medical needs. By harnessing the power of pluripotent stem cells and advanced genetic engineering techniques, Pluri seeks to transform the landscape of medical treatment, offering new hope for patients suffering from a range of conditions. Their commitment to scientific research and development drives their goal to create effective, safe, and accessible cellular therapies for a better quality of life.